Kulkarni Samarth, CEO of CRISPR Therapeutics AG ($CRSP), sold shares on the open market nine times over the past year, totaling nearly $11 million. His most recent sale occurred on March 11, 2026. These sales rank him 1,055th among 11,678 insiders in our database, above the average of $8.6 million per seller and 6 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19687 | $0.00 | 265,521.0000 | 95,985,312 | 8.01% | 0.02% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 19687 | $0.00 | 39,375.0000 | 95,985,312 | 33.33% | 0.02% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Units | 81875 | $0.00 | 81,875.0000 | 95,985,312 | 9999.99% | 0.09% |
| March 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 114249 | $0.00 | 114,249.0000 | 95,985,312 | 9999.99% | 0.12% |
| March 23, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 10020 | $46.78 | 255,501.0000 | 95,985,312 | 3.77% | 0.01% |
| March 16, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 10349 | $48.26 | 245,834.0000 | 95,985,312 | 4.04% | 0.01% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 20625 | $0.00 | 61,875.0000 | 95,985,312 | 25.00% | 0.02% |
| March 14, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 20625 | $0.00 | 256,183.0000 | 95,985,312 | 8.76% | 0.02% |
| March 11, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 9798 | $52.80 | 235,558.0000 | 95,985,312 | 3.99% | 0.01% |
| March 10, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 19250 | $0.00 | 19,250.0000 | 95,985,312 | 50.00% | 0.02% |
| March 10, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19250 | $0.00 | 245,356.0000 | 95,985,312 | 8.51% | 0.02% |
| Feb. 18, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 13250 | $0.00 | 0.0000 | 95,985,312 | 100.00% | 0.01% |
| Feb. 18, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 13250 | $0.00 | 233,073.0000 | 95,985,312 | 6.03% | 0.01% |
| Feb. 19, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 6967 | $52.58 | 226,106.0000 | 95,985,312 | 2.99% | 0.01% |
| Jan. 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 8567 | $52.10 | 279,823.0000 | 95,300,233 | 2.97% | 0.01% |
| Jan. 20, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 21433 | $51.61 | 288,390.0000 | 95,300,233 | 6.92% | 0.02% |
| Jan. 22, 2026 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 60000 | $60.23 | 219,823.0000 | 95,300,233 | 21.44% | 0.06% |
| Dec. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | G | Common Shares | 30000 | $0.00 | 309,823.0000 | 95,300,233 | 8.83% | 0.03% |
| Oct. 16, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 100000 | $0.00 | 300,000.0000 | 85,774,474 | 25.00% | 0.12% |
| Oct. 16, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 100000 | $0.00 | 390,758.0000 | 85,774,474 | 34.39% | 0.12% |
| Oct. 17, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 50895 | $67.91 | 339,863.0000 | 85,774,474 | 13.02% | 0.06% |
| Oct. 14, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 4242 | $66.60 | 290,758.0000 | 85,774,474 | 1.44% | 0.00% |
| Oct. 13, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 8334 | $0.00 | 8,333.0000 | 85,774,474 | 50.00% | 0.01% |
| Oct. 13, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 8334 | $0.00 | 295,000.0000 | 85,774,474 | 2.91% | 0.01% |
| Oct. 3, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 49500 | $0.00 | 49,500.0000 | 85,774,474 | 9999.99% | 0.06% |
| Sept. 17, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | G | Common Shares | 6000 | $0.00 | 286,626.0000 | 85,774,474 | 2.05% | 0.01% |
| Aug. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 13081 | $58.15 | 292,626.0000 | 85,774,474 | 4.28% | 0.02% |
| Aug. 16, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $0.00 | 305,707.0000 | 85,774,474 | 8.91% | 0.03% |
| Aug. 16, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 25000 | $0.00 | 0.0000 | 85,774,474 | 100.00% | 0.03% |
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | Kulkarni Samarth | Director | A | Share Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 133,184,349 | 9999.99% | 0.03% |
| June 12, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Kulkarni Samarth | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| June 2, 2025 | Oruka Therapeutics, Inc. | $ORKA | Kulkarni Samarth | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19688 | $0.00 | 290,738.0000 | 85,774,474 | 7.26% | 0.02% |
| March 21, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 10031 | $41.23 | 280,707.0000 | 85,774,474 | 3.45% | 0.01% |
| March 20, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 19688 | $0.00 | 59,062.0000 | 85,774,474 | 25.00% | 0.02% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 85,774,474 | 9999.99% | 0.13% |
| March 14, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Units | 82500 | $0.00 | 82,500.0000 | 85,774,474 | 9999.99% | 0.10% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 19250 | $0.00 | 38,500.0000 | 85,774,474 | 33.33% | 0.02% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 9000 | $0.00 | 0.0000 | 85,774,474 | 100.00% | 0.01% |
| March 10, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19250 | $0.00 | 276,485.0000 | 85,774,474 | 7.48% | 0.02% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 9973 | $42.42 | 266,512.0000 | 85,774,474 | 3.61% | 0.01% |
| March 11, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 9000 | $0.00 | 275,512.0000 | 85,774,474 | 3.38% | 0.01% |
| March 12, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 4462 | $43.32 | 271,050.0000 | 85,774,474 | 1.62% | 0.01% |
| Feb. 19, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 18360 | $55.21 | 257,235.0000 | 85,774,474 | 6.66% | 0.02% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 13250 | $0.00 | 13,250.0000 | 85,774,474 | 50.00% | 0.02% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 13250 | $0.00 | 294,163.0000 | 85,774,474 | 4.72% | 0.02% |
| Feb. 18, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 11640 | $55.05 | 282,523.0000 | 85,774,474 | 3.96% | 0.01% |
| Feb. 19, 2025 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 6928 | $52.80 | 275,595.0000 | 85,774,474 | 2.45% | 0.01% |
| Dec. 24, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 13751 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 24, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 13751 | $16.21 | 280,913.0000 | 0 | 5.15% | 0.00% |
| Dec. 2, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 15000 | $55.10 | 267,162.0000 | 0 | 5.32% | 0.00% |
| Nov. 11, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 6879 | $56.27 | 282,162.0000 | 0 | 2.38% | 0.00% |
| Nov. 11, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 23121 | $55.43 | 289,041.0000 | 0 | 7.41% | 0.00% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Units | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 13, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 8333 | $0.00 | 316,455.0000 | 0 | 2.70% | 0.00% |
| Oct. 14, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 4293 | $46.28 | 312,162.0000 | 0 | 1.36% | 0.00% |
| Oct. 13, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 8333 | $0.00 | 16,667.0000 | 0 | 33.33% | 0.00% |
| Aug. 8, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | G | Common Shares | 100000 | $0.00 | 308,122.0000 | 0 | 24.50% | 0.00% |
| June 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | Kulkarni Samarth | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2024 | Repare Therapeutics Inc. | $RPTX | Kulkarni Samarth | Not found | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 42,093,293 | 9999.99% | 0.06% |
| June 6, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Kulkarni Samarth | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| April 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19582 | $19.12 | 427,704.0000 | 0 | 4.80% | 0.00% |
| April 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 19582 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 1204 | $60.40 | 408,122.0000 | 0 | 0.29% | 0.00% |
| April 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 18378 | $59.88 | 409,326.0000 | 0 | 4.30% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Units | 78750 | $0.00 | 78,750.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 20000 | $19.12 | 428,122.0000 | 0 | 4.90% | 0.00% |
| March 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 10613 | $71.97 | 417,509.0000 | 0 | 2.48% | 0.00% |
| March 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 9387 | $73.06 | 408,122.0000 | 0 | 2.25% | 0.00% |
| March 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 19,582.0000 | 0 | 50.53% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 9000 | $0.00 | 412,705.0000 | 0 | 2.23% | 0.00% |
| March 10, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 19250 | $0.00 | 413,507.0000 | 0 | 4.88% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 9802 | $78.26 | 403,705.0000 | 0 | 2.37% | 0.00% |
| March 12, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 4583 | $74.44 | 408,122.0000 | 0 | 1.11% | 0.00% |
| March 10, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 19250 | $0.00 | 57,750.0000 | 0 | 25.00% | 0.00% |
| March 11, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 0 | 50.00% | 0.00% |
| Feb. 18, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 13250 | $0.00 | 26,500.0000 | 0 | 33.33% | 0.00% |
| Feb. 18, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 13250 | $0.00 | 400,627.0000 | 0 | 3.42% | 0.00% |
| Feb. 20, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 6370 | $79.67 | 394,257.0000 | 0 | 1.59% | 0.00% |
| Feb. 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 5951 | $81.04 | 388,477.0000 | 0 | 1.51% | 0.00% |
| Feb. 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 12949 | $79.94 | 394,428.0000 | 0 | 3.18% | 0.00% |
| Feb. 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 39,582.0000 | 0 | 33.57% | 0.00% |
| Feb. 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 1100 | $81.66 | 387,377.0000 | 0 | 0.28% | 0.00% |
| Feb. 15, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 20000 | $19.12 | 407,377.0000 | 0 | 5.16% | 0.00% |
| Jan. 29, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 50000 | $19.12 | 437,377.0000 | 0 | 12.91% | 0.00% |
| Jan. 29, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 100,000.0000 | 0 | 33.33% | 0.00% |
| Jan. 29, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 700 | $61.10 | 387,377.0000 | 0 | 0.18% | 0.00% |
| Jan. 29, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 49300 | $60.50 | 388,077.0000 | 0 | 11.27% | 0.00% |
| Jan. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 20000 | $19.12 | 407,377.0000 | 0 | 5.16% | 0.00% |
| Jan. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 20000 | $62.50 | 387,377.0000 | 0 | 4.91% | 0.00% |
| Jan. 16, 2024 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 59,582.0000 | 0 | 25.13% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 52500 | $0.00 | 52,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 13, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Unit | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Centessa Pharmaceuticals plc | $CNTA | Kulkarni Samarth | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Repare Therapeutics Inc. | $RPTX | Kulkarni Samarth | Director | A | Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 79,582.0000 | 0 | 23.90% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 7301 | $63.61 | 405,076.0000 | 0 | 1.77% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 5999 | $64.46 | 399,077.0000 | 0 | 1.48% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 9300 | $65.63 | 389,777.0000 | 0 | 2.33% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 2400 | $66.83 | 387,377.0000 | 0 | 0.62% | 0.00% |
| May 30, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $19.12 | 412,377.0000 | 0 | 6.45% | 0.00% |
| April 25, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 20607 | $50.50 | 391,770.0000 | 0 | 5.00% | 0.00% |
| April 25, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 4393 | $51.45 | 387,377.0000 | 0 | 1.12% | 0.00% |
| April 25, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 104,582.0000 | 0 | 19.29% | 0.00% |
| April 25, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $19.12 | 412,377.0000 | 0 | 6.45% | 0.00% |
| March 29, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $19.12 | 412,377.0000 | 0 | 6.45% | 0.00% |
| March 29, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 19719 | $44.37 | 392,658.0000 | 0 | 4.78% | 0.00% |
| March 29, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 5281 | $44.78 | 387,377.0000 | 0 | 1.34% | 0.00% |
| March 29, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 129,582.0000 | 0 | 16.17% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Stock Option (Right to Buy) | 188000 | $0.00 | 188,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | A | Restricted Stock Units | 77000 | $0.00 | 77,000.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 11833 | $0.00 | 387,821.0000 | 0 | 3.15% | 0.00% |
| March 13, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | F | Common Shares | 5358 | $43.22 | 382,463.0000 | 0 | 1.38% | 0.00% |
| March 11, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 9000 | $0.00 | 18,000.0000 | 0 | 33.33% | 0.00% |
| March 11, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 9000 | $0.00 | 391,463.0000 | 0 | 2.35% | 0.00% |
| March 13, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | F | Common Shares | 4086 | $43.22 | 387,377.0000 | 0 | 1.04% | 0.00% |
| March 10, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 11833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 10180 | $47.71 | 390,808.0000 | 0 | 2.54% | 0.00% |
| Feb. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 1100 | $49.20 | 375,988.0000 | 0 | 0.29% | 0.00% |
| Feb. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 154,582.0000 | 0 | 13.92% | 0.00% |
| Feb. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 13720 | $48.57 | 377,088.0000 | 0 | 3.51% | 0.00% |
| Feb. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $19.12 | 400,988.0000 | 0 | 6.65% | 0.00% |
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Restricted Stock Units | 13250 | $0.00 | 39,750.0000 | 0 | 25.00% | 0.00% |
| Feb. 21, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | F | Common Shares | 6373 | $48.26 | 375,988.0000 | 0 | 1.67% | 0.00% |
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 13250 | $0.00 | 382,361.0000 | 0 | 3.59% | 0.00% |
| Jan. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 179,582.0000 | 0 | 12.22% | 0.00% |
| Jan. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | M | Common Shares | 25000 | $19.12 | 394,111.0000 | 0 | 6.77% | 0.00% |
| Jan. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 23200 | $51.54 | 369,111.0000 | 0 | 5.91% | 0.00% |
| Jan. 27, 2023 | CRISPR Therapeutics AG | $CRSP | Kulkarni Samarth | Chief Executive Officer | S | Common Shares | 1800 | $50.60 | 392,311.0000 | 0 | 0.46% | 0.00% |